Monthly Archives: January 2012

PHOENIX (MedPage Today) — Small temperature changes in the oral mucosa early in the course of chemoradiation correlated with increasing grade of mucositis in patients with head and neck cancer.

PHOENIX (MedPage Today) — PET/CT imaging showed good accuracy for identifying head and neck patients who can avoid neck dissection after definitive chemoradiation therapy, according to a retrospective study.

(MedPage Today) — An unexpected feedback mechanism in cell signaling pathways may explain why some colorectal cancers don’t respond to a drug that theoretically should work, researchers reported.

PHOENIX (MedPage Today) — Adding chemotherapy to radiation therapy failed to improve disease control or survival in patients with high-risk head and neck cancer, long-term follow-up of a randomized trial showed.

Libertas is pleased to announce that during the week 23 – 27 January 2012 production commenced for the following articles:Biomarker InsightsDetection of 1p19q deletion by real-time comparative quantitative PCR

(MedPage Today) — The American Society of Hematology is challenging the major college sports organization over its policy on sickle cell trait testing for athletes.

(MedPage Today) — Tops in this week’s edition, research in mice suggests that taking protein out of patients’ diets a few days before surgery could reduce the risk of complications.

(MedPage Today) — Another angiogenesis blocker, axitinib (Inlyta), has won FDA approval as a second-line treatment for advanced kidney cancer, the agency said Friday.

PHOENIX (MedPage Today) — Conventional therapy for head and neck cancer appeared more toxic and less effective for patients with co-existing HIV infection, according to data presented here.

(MedPage Today) — Treatment of high-grade prostate cancer with brachytherapy significantly reduced prostate cancer-specific mortality compared with external beam radiation alone, results of a large study showed.